Financial Statements

Bayer Group Consolidated Statements of Financial Position

			[Table 4.3]
	Note	Dec. 31, 2010	Dec. 31, 2011
		€ million	€ million
Noncurrent assets
Goodwill	[17]	9,002	9,160
Other intangible assets	[17]	11,161	10,295
Property, plant and equipment	[18]	9,835	9,823
Investments accounted for using the equity method	[19]	354	319
Other financial assets	[20]	1,164	1,364
Other receivables	[23]	498	425
Deferred taxes	[14]	1,174	1,311
		33,188	32,697
Current assets
Inventories	[21]	6,104	6,368
Trade accounts receivable	[22]	6,668	7,061
Other financial assets	[20]	1,008	2,784
Other receivables	[23]	1,336	1,628
Claims for income tax refunds		362	373
Cash and cash equivalents		2,840	1,770
Assets held for sale	[6.3]	-	84
		18,318	20,068

Total assets		51,506	52,765

Equity	[24]
Capital stock of Bayer AG		2,117	2,117
Capital reserves of Bayer AG		6,167	6,167
Other reserves		10,549	10,928
Equity attributable to Bayer AG stockholders		18,833	19,212
Equity attributable to non-controlling interest		63	59
		18,896	19,271

Noncurrent liabilities
Provisions for pensions and other post-employment benefits	[25]	7,305	7,870
Other provisions	[26]	1,478	1,649
Financial liabilities	[27]	9,944	7,995
Other liabilities	[29]	471	474
Deferred taxes	[14]	2,577	2,116
		21,775	20,104
Current liabilities
Other provisions	[26]	3,870	4,218
Financial liabilities	[27]	1,889	3,684
Trade accounts payable	[28]	3,497	3,779
Income tax liabilities	[26.1]	62	76
Other liabilities	[29]	1,517	1,630
Provisions directly related to assets held for sale	[6.3]	-	3
		10,835	13,390

Total equity and liabilities		51,506	52,765